Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages

  Peter, Andreas ^a   Stefan, Norbert ^a   Cegan, Alexander ^c   Walenta, Mareike ^a   Wagner, Silvia ^b   Königsrainer, Alfred ^b   Königsrainer, Ingmar ^b   Machicao, Fausto ^a   Schick, Fritz ^b   Häring, Hans Ulrich ^a   Schleicher, Erwin ^a  

^a Department of Internal Medicine   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF PARDUBICE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE ALPHA; ACETYL COENZYME A CARBOXYLASE BETA; FATTY ACID SYNTHASE; GLUCOKINASE; MESSENGER RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME SPECIFICITY; FATTY LIVER; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; LIPOGENESIS; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; FATTY LIVER; FEMALE; GLUCOKINASE; HUMANS; LIPOGENESIS; LIVER; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 79960086105     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2017     Document Type: Article

References (20)

1. Matschinsky F, Liang Y, Kesavan P, Wang L, Froguel P, Velho G, Cohen D, Permutt MA, Tanizawa Y, Jetton TL 1993 Glucokinase as pancreatic β cell glucose sensor and diabetes gene. J Clin Invest 92:2092-2098 (Pubitemid 23333511)
2. Iynedjian PB 2009 Molecular physiology of mammalian glucokinase. Cell Mol Life Sci 66:27-42
3. Matschinsky FM 2009 Assessing the potential of glucokinase activators in diabetes therapy. Nat Rev Drug Discov 8:399-416
4. Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF 2003 Allosteric activators of glucokinase: potential role in diabetes therapy. Science 301:370-373 (Pubitemid 36877072)
5. Postic C, Girard J 2008 The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34:643-648
6. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ 2005 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351 (Pubitemid 40629054)
7. Morral N, Edenberg HJ, Witting SR, Altomonte J, Chu T, Brown M 2007 Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. J Lipid Res 48:1499-1510 (Pubitemid 47312012)
8. Niswender KD, Shiota M, Postic C, Cherrington AD, Magnuson MA 1997 Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 272:22570-22575 (Pubitemid 27386069)
9. O'Doherty RM, Lehman DL, Télémaque-Potts S, Newgard CB 1999 Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48:2022-2027 (Pubitemid 29458366)
10. Ferre T, Riu E, Franckhauser S, Agudo J, Bosch F 2003 Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia 46:1662-1668 (Pubitemid 38005328)
11. Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho-Melander M, Gloyn AL 2009 The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 18:4081-4088
12. Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, Tewhey R, Rieder MJ, Hall J, Abecasis G, Tai ES, Welch C, Arnett DK, Lyssenko V, Lindholm E, Saxena R, de Bakker PI, Burtt N, Voight BF, Hirschhorn JN, Tucker KL, Hedner T, Tuomi T, Isomaa B, Eriksson KF, Taskinen MR, Wahlstrand B, Hughes TE, Parnell LD, Lai CQ, Berglund G, Peltonen L, Vartiainen E, Jousilahti P, Havulinna AS, Salomaa V, Nilsson P, Groop L, Altshuler D, Ordovas JM, Kathiresan S 2008 Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57:3112-3121
13. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Boström K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, et al. 2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336 (Pubitemid 46871653)
14. Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Königsrainer I, Königsrainer A, Schick F, Fritsche A, Häring HU, Stefan N 2009 Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58:2616-2623
15. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, Hirsch J 1996 Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 97:2081-2091 (Pubitemid 26143963)
16. Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Königsrainer A, Königsrainer I, Häring HU, Schleicher E 2009 Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem 55:2113-2120
17. Hansmannel F, Mordier S, Iynedjian PB 2006 Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor. Biochem J 399:275-283 (Pubitemid 44570290)
18. Stefan N, Kantartzis K, Häring HU 2008 Causes and metabolic consequences of fatty liver. Endocr Rev 29:939-960
19. Iynedjian PB 1998 Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene. Biochem J 333(Pt 3):705-712 (Pubitemid 28398539)
20. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G 2005 Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54: 3541-3546 (Pubitemid 43334347)